488 related articles for article (PubMed ID: 25824274)
1. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
2. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
5. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
Iorizzo LJ; Chocron I; Lumbang W; Stasko T
Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
[TBL] [Abstract][Full Text] [Related]
6. Surgical margins for melanoma in situ.
Kunishige JH; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2012 Mar; 66(3):438-44. PubMed ID: 22196979
[TBL] [Abstract][Full Text] [Related]
7. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
9. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
10. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
Cheraghlou S; Christensen SR; Leffell DJ; Girardi M
JAMA Dermatol; 2021 May; 157(5):531-539. PubMed ID: 33787836
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery versus wide local excision for melanoma in situ: analysis of a nationwide database.
Phan K; Loya A
Int J Dermatol; 2019 Jun; 58(6):697-702. PubMed ID: 30604517
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Degesys CA; Powell HB; Hsia LB; Merritt BG
Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
[TBL] [Abstract][Full Text] [Related]
13. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
Demer AM; Hanson JL; Maher IA; Liszewski W
JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
[TBL] [Abstract][Full Text] [Related]
14. Mohs surgery for melanoma in situ.
Kwon SY; Miller SJ
Dermatol Clin; 2011 Apr; 29(2):175-83, vii-viii. PubMed ID: 21421143
[TBL] [Abstract][Full Text] [Related]
15. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.
Singh B; Qureshi MM; Truong MT; Sahni D
J Am Acad Dermatol; 2018 Jul; 79(1):126-134.e3. PubMed ID: 29408552
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
17. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
Hanson J; Demer A; Liszewski W; Foman N; Maher I
J Am Acad Dermatol; 2020 Jan; 82(1):149-155. PubMed ID: 31473297
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.
Hunger RE; Angermeier S; Seyed Jafari SM; Ochsenbein A; Shafighi M
J Am Acad Dermatol; 2015 Jun; 72(6):1054-9. PubMed ID: 25877659
[TBL] [Abstract][Full Text] [Related]
19. Digit-Sparing Mohs Surgery for Melanoma.
Terushkin V; Brodland DG; Sharon DJ; Zitelli JA
Dermatol Surg; 2016 Jan; 42(1):83-93. PubMed ID: 26655701
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
